BioTrack Capital
VC Fund
Shanghai, China
BioTrack Capital is a VC fund in Shanghai focused on Biotechnology and Health Care. BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.
- Total investments:
- 93
- Last investment:
- Lead investor:
- 32%
Last updated:
For AI agents: llms.txt
Industries BioTrack Capital invests in
Stages BioTrack Capital invests in
Countries BioTrack Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $16M–$168M
- Series A
- $14M–$45M
- Series B
- $15M–$147M
Investment Focus
Industry
- Biotechnology 33 (35%)
- Health Care 32 (34%)
- Medical 24 (26%)
- Pharmaceutical 13 (14%)
- Manufacturing 12 (13%)
Stage
- Series A 28 (30%)
- Series B 25 (27%)
- Seed 14 (15%)
- Angel 5 (5%)
- Venture - Series Unknown 5 (5%)
Country
- China 58 (62%)
- United States 8 (9%)
- Singapore 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Feng Tao
Co-Founder & Partner
|
Co-Founder & Partner | Total investments: 0 | Find email | |
Jiacong Guo
Executive Director
|
Executive Director | Total investments: 3 | Find email | |
Kevin (Penghui) Chen
Founder & Partner
|
Founder & Partner | Total investments: 7 | Find email | |
|
Zhang Ye
Project Manager
|
Project Manager | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Zhiyue Space Intelligence
|
Zhiyue Space Intelligence specializes in robotic brain and brain systems. | Angel / Jun 23, 2026 | |
|
Taiyi Quantum
|
Taiyi Quantum is dedicated to encouraging innovation in the distribution and implementation of quantum computing technology, as well as developing sophisticated quantum algorithms and delivering tailored computing solutions for businesses and research institutes. | $44.4M / Seed / Jun 17, 2026 | |
Carbonology
|
Carbonology is a carbon capture company that produces fuels, chemicals, and polyesters. | Series A / Jun 12, 2026 | |
|
Carbon Life
|
Carbon Life is a carbon sequestration technology developer. It is mainly engaged in carbon emission reduction, carbon conversion, carbon capture, carbon sequestration technology research and development. | Series A / Jun 12, 2026 | |
|
Carbonology
|
Carbonology is a carbon capture company that produces fuels, chemicals, and polyesters. | Seed / Jun 12, 2026 | |
|
Dongsheng Fusion
|
Dongsheng Fusion is a magnetic confinement fusion technology company that develops miniaturized fusion power plant technology. | Seed / May 27, 2026 | |
Aureka Biotechnologies
|
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness. | $35M / Series A / Apr 28, 2026 | |
Syneron
|
Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals. | $150M / Series B / Mar 31, 2026 | |
GasGene
|
GasGene ferments industrial waste gas to generate bulk chemicals. | $14.5M / Venture - Series Unknown / Mar 23, 2026 | |
PrinoPharma
|
PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets. | $14.5M / Angel / Mar 10, 2026 | |
| See all 93 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does BioTrack Capital invest in?
BioTrack Capital invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Series B stage. Most of the 93 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is BioTrack Capital's check size?
BioTrack Capital typically joins rounds of $16M–$168M at Seed, $14M–$45M at Series A and $15M–$147M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds BioTrack Capital participates in.
How do I contact BioTrack Capital?
Public channels for BioTrack Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BioTrack Capital?
The team at BioTrack Capital includes Feng Tao (Co-Founder & Partner), Jiacong Guo (Executive Director) and Kevin (Penghui) Chen (Founder & Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
